Innovus Pharma Announces Allowance of Patent in Europe for Its J. Regia Product
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
LA JOLLA, Calif., April 23, 2013 (GLOBE NEWSWIRE) -- Innovus Pharmaceuticals, Inc., ("Innovus Pharma") www.innovuspharma.com (OTCBB:INNV) today announced that the European Patent Office ("EPO") has issued an official decision to grant the company's patent entitled, "Process for Preparing an Anti-Microbial Fraction from Juglans Regia."
Help employers find you! Check out all the jobs and post your resume.
LA JOLLA, Calif., April 23, 2013 (GLOBE NEWSWIRE) -- Innovus Pharmaceuticals, Inc., ("Innovus Pharma") www.innovuspharma.com (OTCBB:INNV) today announced that the European Patent Office ("EPO") has issued an official decision to grant the company's patent entitled, "Process for Preparing an Anti-Microbial Fraction from Juglans Regia."
Help employers find you! Check out all the jobs and post your resume.